MAXHEALTH - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.6
| Stock Code | MAXHEALTH | Market Cap | 96,643 Cr. | Current Price | 993 ₹ | High / Low | 1,314 ₹ |
| Stock P/E | 137 | Book Value | 87.3 ₹ | Dividend Yield | 0.15 % | ROCE | 12.5 % |
| ROE | 9.45 % | Face Value | 10.0 ₹ | DMA 50 | 1,003 ₹ | DMA 200 | 1,062 ₹ |
| Chg in FII Hold | -5.16 % | Chg in DII Hold | 5.12 % | PAT Qtr | 200 Cr. | PAT Prev Qtr | 160 Cr. |
| RSI | 49.6 | MACD | 3.48 | Volume | 24,37,699 | Avg Vol 1Wk | 16,29,336 |
| Low price | 903 ₹ | High price | 1,314 ₹ | PEG Ratio | 4.35 | Debt to equity | 0.08 |
| 52w Index | 21.9 % | Qtr Profit Var | 5.45 % | EPS | 7.10 ₹ | Industry PE | 47.1 |
📊 Max Healthcare (MAXHEALTH) is trading near its 50 DMA (₹1,003) but below its 200 DMA (₹1,062), reflecting short-term stability but long-term weakness. RSI at 49.6 indicates neutral momentum, while MACD (3.48) shows mild bullish divergence. Bollinger Bands suggest consolidation with limited breakout potential. Current volume (24.3 lakh) is above the 1-week average (16.3 lakh), showing strong participation despite weak trend strength.
💡 Optimal Entry: ₹950–₹980 (near support zone)
🚪 Exit if Holding: Profit-taking zone around ₹1,250–₹1,280; Stop-loss below ₹930
📈 Trend Status: Consolidating with neutral bias
✅ Positive
- Quarterly PAT growth (₹160 Cr → ₹200 Cr)
- DII holdings increased significantly (+5.12%)
- EPS at ₹7.10 supports profitability visibility
- Low debt-to-equity ratio (0.08)
- ROE (9.45%) and ROCE (12.5%) show moderate efficiency
⚠️ Limitation
- Trading below 200 DMA, limiting long-term upside
- High valuation (P/E 137 vs industry 47.1)
- PEG ratio at 4.35 indicates poor growth-adjusted valuation
- Dividend yield remains weak (0.15%)
- FII holdings decreased (-5.16%)
📉 Company Negative News
- Valuation concerns due to high P/E multiples
- Decline in foreign institutional participation
- Weak dividend yield
📈 Company Positive News
- Quarterly PAT growth supports earnings momentum
- DII accumulation signals domestic investor confidence
- Debt-light balance sheet ensures financial stability
🏭 Industry
- Healthcare sector average PE at 47.1, MAXHEALTH trades at a premium (137)
- Sector outlook stable with steady demand but valuation pressures
🔎 Conclusion
MAXHEALTH is consolidating with neutral momentum and mild bullish signals. Entry near ₹950–₹980 offers a controlled risk setup, while exits around ₹1,250–₹1,280 are advisable. Strong PAT growth, DII support, and low debt are positives, but stretched valuations and declining FII holdings limit attractiveness. Suitable for cautious swing trades; long-term investors should wait for valuation normalization and sustained strength above 200 DMA.